InhiProt is a start-up biotech company that aims to develop novel treatments for multiple myeloma, an incurable cancer of bone marrow.

Call 2020

The 2020 Call for Application is now close. Stay tuned for the 2021 Call



Receive notifications about the YEi Start in France program (Call for applications, announcement of the laureates, YEi events, etc.)

Social Links